- $291.71m
- $546.92m
- $106.77m
- 52
- 81
- 68
- 74
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 59.4 | 73.1 | 71.2 | 83.4 | 88.3 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 58.8 | 63.9 | 71.2 | 83.4 | 87.5 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 29.4 | 22.7 | 35 | 45 | 39.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23.7 | 18.4 | 27.8 | 35.8 | 31.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 23.7 | 18.4 | 27.8 | 35.8 | 31.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23.7 | 18.4 | 27.8 | 35.8 | 31.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.45 | 2.69 | 3.19 | 4.11 | 3.68 |
Dividends per Share | |||||
Special Dividends per Share |